Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A number of immune regulatory cellular therapies, including regulatory T cells and mesenchymal stromal cells, have emerged as novel alternative therapies for the control of transplant alloresponses. Clinical studies have demonstrated their feasibility and safety, however developing our understanding of the impact of cellular therapeutics in vivo requires advanced immune monitoring strategies. To accurately monitor the immune response, a combination of complementary methods is required to measure the cellular and molecular phenotype as well as the function of cells involved. In this review we focus on the current immune monitoring strategies and discuss which methods may be utilized in the future.

Original publication

DOI

10.3389/fimmu.2021.664244

Type

Journal article

Journal

Front Immunol

Publication Date

2021

Volume

12

Keywords

cell therapy, immune monitoring, mesenchymal stromal cell, regulatory T cell, transplantation, Animals, Cell Transplantation, Cell- and Tissue-Based Therapy, Clinical Decision-Making, Clinical Trials as Topic, Disease Management, Humans, Monitoring, Immunologic, Organ Specificity, Treatment Outcome